West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Icon Wealth Advisors LLC

Icon Wealth Advisors LLC trimmed its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 31.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,194 shares of the medical instruments supplier’s stock after selling 560 shares during the period. Icon Wealth Advisors LLC’s holdings in West Pharmaceutical Services were worth $358,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in WST. Ballentine Partners LLC boosted its position in shares of West Pharmaceutical Services by 4.7% in the second quarter. Ballentine Partners LLC now owns 742 shares of the medical instruments supplier’s stock worth $244,000 after acquiring an additional 33 shares during the last quarter. RFG Advisory LLC grew its stake in shares of West Pharmaceutical Services by 2.3% during the 2nd quarter. RFG Advisory LLC now owns 1,499 shares of the medical instruments supplier’s stock valued at $494,000 after buying an additional 34 shares during the period. Covestor Ltd increased its holdings in shares of West Pharmaceutical Services by 14.3% during the 3rd quarter. Covestor Ltd now owns 320 shares of the medical instruments supplier’s stock worth $96,000 after buying an additional 40 shares during the last quarter. UMB Bank n.a. raised its position in shares of West Pharmaceutical Services by 1.2% in the 3rd quarter. UMB Bank n.a. now owns 3,941 shares of the medical instruments supplier’s stock worth $1,183,000 after buying an additional 47 shares during the period. Finally, Envestnet Portfolio Solutions Inc. boosted its holdings in West Pharmaceutical Services by 0.4% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 12,554 shares of the medical instruments supplier’s stock valued at $4,135,000 after acquiring an additional 49 shares during the last quarter. Hedge funds and other institutional investors own 93.90% of the company’s stock.

Insider Buying and Selling

In related news, VP Charles Witherspoon sold 703 shares of the business’s stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $310.40, for a total transaction of $218,211.20. Following the transaction, the vice president now directly owns 1,253 shares of the company’s stock, valued at approximately $388,931.20. The trade was a 35.94 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.53% of the stock is owned by corporate insiders.

West Pharmaceutical Services Stock Performance

Shares of NYSE:WST opened at $325.44 on Friday. The business has a 50-day moving average of $308.46 and a two-hundred day moving average of $313.41. The firm has a market capitalization of $23.57 billion, a PE ratio of 48.28, a P/E/G ratio of 24.42 and a beta of 1.00. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.00 and a quick ratio of 2.23. West Pharmaceutical Services, Inc. has a 12 month low of $265.00 and a 12 month high of $413.70.

West Pharmaceutical Services (NYSE:WST) last posted its earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.50 by $0.35. The firm had revenue of $746.90 million during the quarter, compared to the consensus estimate of $709.62 million. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. The company’s revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.16 EPS. As a group, research analysts forecast that West Pharmaceutical Services, Inc. will post 6.67 earnings per share for the current year.

West Pharmaceutical Services Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 20th. Investors of record on Wednesday, November 13th were issued a dividend of $0.21 per share. This is a positive change from West Pharmaceutical Services’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.84 annualized dividend and a dividend yield of 0.26%. West Pharmaceutical Services’s payout ratio is presently 12.46%.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.